AlphaCentric Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,047
Closed -$87.8K 267
2026
Q1
$87.8K Buy
2,047
+129
+7% +$5.55K 0.09% 223
2025
Q4
$84.1K Buy
+1,918
New +$79.3K 0.08% 227
2023
Q4
Sell
-30,000
Closed -$656K 250
2023
Q3
$656K Sell
30,000
-3,000
-9% -$62.8K 0.37% 82
2023
Q2
$631K Hold
33,000
0.35% 88
2023
Q1
$641K Hold
33,000
0.44% 75
2022
Q4
$529K Buy
+33,000
New +$538K 0.52% 69
2021
Q4
$695K Buy
38,000
+15,000
+65% +$287K 0.2% 51
2021
Q3
$486K Buy
23,000
+2,500
+12% +$46.4K 0.12% 69
2021
Q2
$374K Buy
20,500
+6,500
+46% +$152K 0.1% 78
2021
Q1
$316K Hold
14,000
0.11% 72
2020
Q4
$281K Buy
14,000
+11,000
+367% +$230K 0.12% 44
2020
Q3
$73K Sell
3,000
-100
-3% -$2.33K 0.04% 82
2020
Q2
$74K Buy
+3,100
New +$71.8K 0.04% 66

Other funds holding EXEL

AlphaCentric Advisors's EXEL Position: Q2 2026 in Review

AlphaCentric Advisors sold out of Exelixis (EXEL) in Q2 2026, closing a stake of 2,047 shares — an estimated $87.8K sold.

AlphaCentric Advisors first reported a position in EXEL in Q2 2020 and held it in 13 quarters. The position peaked at $695K in Q4 2021. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • AlphaCentric Advisors reported no remaining Exelixis position as of Q2 2026 after selling out during the quarter.
  • AlphaCentric Advisors sold 2,047 Exelixis shares in Q2 2026, an estimated $87.8K.
  • AlphaCentric Advisors first reported a position in Exelixis in Q2 2020 and held it in 13 quarters.
  • AlphaCentric Advisors's Exelixis position peaked at $695K in Q4 2021.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on AlphaCentric Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.